Targeting PKM2 and GAPDH by baicalein and corilagin from TCM reduces lactylation and enhance cisplatin sensitivity in lung cancer.

Authors

Caifeng Li, Zhao Cui, Wenlong Sun, Wei Liu, Shiwen Deng, Junxian Cao, Xuxia Cao, Xun Wang, Peng Chen, Hongjun Yang

Published in

Phytomedicine : international journal of phytotherapy and phytopharmacology. Volume 160. Pages 158690. Aug 05, 2026. Epub Aug 05, 2026.

Abstract

Protein lactylation plays a key role in cancer progression and chemotherapy sensitivity. Glycolysis inhibitors offer promise, particularly through combination strategies to counter metabolic compensation.
This study aims to identify glycolysis-targeting active ingredients from Traditional Chinese Medicine (TCM) and to investigate their enhanced effect in reducing lactylation to inhibit lung cancer.
We first screened heat-clearing and detoxifying TCM herbs based on their effects on lactate levels, and then we developed a lactate-producing key enzyme protein stability chip (L-PTSC) to further screen the selected herbs and identify their targets. Through semi-preparative separation of herbal extracts, we identified the active components and characterized their target interactions. Finally, the efficacy of the triple combination (baicalein + corilagin + cisplatin) was validated in multiple lung cancer models, including cell lines, resistant lines, organoids, and xenografts.
Extracts from Scutellaria baicalensis (SBG) and Geranium wilfordii (GWM) significantly inhibited glycolysis. Baicalein (from SBG) and corilagin (from GWM) were identified as candidate of PKM2 and GAPDH binders through l-PTSC. Given the central role of PKM2 and GAPDH in glycolysis, we systematically evaluated the enhanced antitumor effects of baicalein and corilagin using the Combination Index (CI) method via CompuSyn software (Chou-Talalay approach). Mechanistic investigations revealed that the triple combination treatment associated with lowered global protein lactylation levels, with AARS1 and MRE11 being particularly affected.
This study established a natural product-based targeting strategy, identifying baicalein and corilagin from TCM herbs that engage PKM2 and GAPDH, and are associated with reduced lactylation and enhanced cisplatin sensitivity in lung cancer.

PMID:
42604625
Bibliographic data and abstract were imported from PubMed on 17 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.